ISOFLURANE
General Anesthesia
Duke UniversitySmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
12 Active assets in the General Anesthesia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Remimazolam Seoul National University Bundang Hospital | Phase 4 | BB |
PROPOFOL University Hospital, Clermont-Ferrand | Phase 1 | CC |
FENTANYL Medical University of Lodz | N/A | D |
RAMIFENTANYL University Hospital, Clermont-Ferrand | N/A | D |
Oxygen The Cleveland Clinic | N/A | D |
View all 14 →
Same molecule, other indications
ISOFLURANE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →